Annalisa Bosi | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Dr. Annalisa Bosi | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

University of Insubria | Italy

Dr. Annalisa Bosi is a distinguished researcher with 909 citations, 29 scientific documents, and an h-index of 15, reflecting her strong impact in the fields of immunology, gastrointestinal pathology, and microbiota–gut–brain axis research. Her early work focused on the phenotypic and functional characterization of innate immune components, particularly NK cells and macrophages, examining their role in tumor pathogenesis and their modulation by chemotherapeutic agents or plant-derived molecules. She later advanced her research to explore molecular and cellular mechanisms underlying major gastrointestinal diseases such as ischemia, intestinal inflammation, and enteric neuropathy, identifying the regulatory role of hyaluronic acid homeostasis in tissue repair. Her recent studies investigate gut microbiota, dysbiosis, and their influence on neurodevelopment and tumor etiopathogenesis, with growing emphasis on prebiotic and probiotic interventions. Dr. Bosi has contributed significantly to understanding experimental models of gut pathology, neuromuscular dysfunction, immunomodulation by virome components, and sex-dependent microbial effects. Her publications span high-impact journals, covering topics such as microbiota–immune interactions, ischemia–reperfusion injury, cytokine–phage crosstalk, and neuroimmune modulation. Through multidisciplinary approaches integrating molecular biology, immunology, and neurogastroenterology, her work continues to shape emerging perspectives on host–microbiota communication and its relevance to disease mechanisms and therapeutic strategies.

Profiles : Scopus | Orcid

Featured Publications

Bosi, A., Baranzini, N., Ponti, A., Moretto, P., Moro, E., Crema, F., Cianci, R., Karousou, E., Viola, M., Passi, A., et al. (2025). Intestinal ischemia/reperfusion injury influences hyaluronan homeostasis in the rat brain. International Journal of Molecular Sciences, 26(20), 10064.

Cianci, R., Caldarelli, M., Brani, P., Bosi, A., Ponti, A., Giaroni, C., & Baj, A. (2025). Cytokines meet phages: A revolutionary pathway to modulating immunity and microbial balance. Biomedicines, 13(5), 1202.

Faggin, S., Cerantola, S., Caputi, V., Tietto, A., Stocco, E., Bosi, A., Ponti, A., Bertazzo, A., Macchi, V., Porzionato, A., et al. (2025). Toll-like receptor 4 deficiency ameliorates experimental ileitis and enteric neuropathy: Involvement of nitrergic and 5-hydroxytryptaminergic neurotransmission. British Journal of Pharmacology, 182(8), 1803–1822.

Brani, P., Manzoor, H. Z., Spezia, P. G., Vigezzi, A., Ietto, G., Dalla Gasperina, D., Minosse, C., Bosi, A., Giaroni, C., Carcano, G., et al. (2025). Torque Teno Virus: Lights and shades. Viruses, 17(3), 334.

Dal Lago, S., Brani, P., Ietto, G., Dalla Gasperina, D., Gianfagna, F., Giaroni, C., Bosi, A., Drago Ferrante, F., Genoni, A., Manzoor, H. Z., et al. (2024). Torque Teno Virus: A promising biomarker in kidney transplant recipients. International Journal of Molecular Sciences, 25(14), 7744.

Giambra, V., Pagliari, D., Rio, P., Totti, B., Di Nunzio, C., Bosi, A., Giaroni, C., Gasbarrini, A., Gambassi, G., & Cianci, R. (2023). Gut microbiota, inflammatory bowel disease, and cancer: The role of guardians of innate immunity. Cells, 12(22), 2654.

Bosi, A., Banfi, D., Bistoletti, M., Catizzone, L. M., Chiaravalli, A. M., Moretto, P., Moro, E., Karousou, E., Viola, M., Giron, M. C., et al. (2022). Hyaluronan regulates neuronal and immune function in the rat small intestine and colonic microbiota after ischemic/reperfusion injury. Cells, 11(21), 3370.

Bosi, A., Banfi, D., Bistoletti, M., Moretto, P., Moro, E., Crema, F., Maggi, F., Karousou, E., Viola, M., Passi, A., et al. (2021). Hyaluronan: A neuroimmune modulator in the microbiota–gut axis. Cells, 11(1), 126.

Cerantola, S., Caputi, V., Contarini, G., Mereu, M., Bertazzo, A., Bosi, A., Banfi, D., Mantini, D., Giaroni, C., & Giron, M. C. (2021). Dopamine transporter genetic reduction induces morpho-functional changes in the enteric nervous system. Biomedicines, 9(5), 465.

Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021). Impact of microbial metabolites on microbiota–gut–brain axis in inflammatory bowel disease. International Journal of Molecular Sciences, 22(4), 1623.

Baci, D., Bosi, A., Parisi, L., Buono, G., Mortara, L., Ambrosio, G., & Bruno, A. (2020). Innate immunity effector cells as inflammatory drivers of cardiac fibrosis. International Journal of Molecular Sciences, 21(19), 7165.

Baci, D., Bosi, A., Gallazzi, M., Rizzi, M., Noonan, D. M., Poggi, A., Bruno, A., & Mortara, L. (2020). The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: A focus on innate immunity cells as therapeutic effectors. International Journal of Molecular Sciences, 21(9), 3125.

Bosi, A., Banfi, D., Bistoletti, M., Giaroni, C., & Baj, A. (2020). Tryptophan metabolites along the microbiota–gut–brain axis: An interkingdom communication system influencing the gut in health and disease. International Journal of Tryptophan Research, 13, 1–18.

Jialu Xu | Neuroscience | Best Researcher Award

Dr. Jialu Xu | Neuroscience | Best Researcher Award

Huazhong University of Science and Technology | China

Author Profile 

Orcid

Early Academic Pursuits 🎓

Dr. Jialu Xu has shown remarkable dedication to scientific research from early on in his academic journey. Having pursued a strong foundation in biomedical sciences, his commitment to understanding complex biological mechanisms has been evident through his involvement in various academic projects. His educational background at Huazhong University of Science and Technology laid the groundwork for his focus on biomedical research, particularly in the study of cognitive impairment and its underlying causes.

Professional Endeavors 💼

Dr. Xu is currently affiliated with Huazhong University of Science and Technology, where he actively contributes to research at Tongji Hospital. His work is interdisciplinary, spanning both clinical and laboratory settings. Dr. Xu's professional role has been instrumental in investigating the intricate pathways involved in cognitive diseases, where he collaborates with colleagues on cutting-edge research projects aimed at improving patient care and advancing scientific knowledge.

Contributions and Research Focus 🔬

One of Dr. Xu's most significant contributions is his study on how high-carbohydrate diets can lead to cognitive impairment. His research, published in Biomedicines in July 2024, demonstrates how these diets promote amyloid burden and tau phosphorylation through the PI3K/Akt/GSK-3β pathway in db/db mice. This groundbreaking work provides insights into the molecular mechanisms underlying neurodegenerative diseases like Alzheimer’s, opening doors to potential new therapeutic interventions. His research interests encompass neurology, metabolic disorders, and molecular pathways related to brain health.

Accolades and Recognition 🏆

Dr. Xu’s innovative research has garnered recognition in the scientific community. His recent publication in Biomedicines has been well-received, highlighting his growing reputation as a leader in cognitive impairment research. His work has contributed to expanding the knowledge base around neurodegenerative disorders and is recognized for its potential impact on future treatments.

Impact and Influence 🌍

Dr. Xu’s research not only influences the academic community but also has far-reaching implications for public health, especially in areas related to diet and neurodegenerative diseases. His findings on the impact of high-carbohydrate diets on cognitive health offer valuable guidance for clinicians and dieticians in developing preventive strategies and interventions for at-risk populations.

Legacy and Future Contributions 🌟

As Dr. Xu continues to expand his research, his future contributions are poised to significantly advance the understanding of cognitive diseases. His ongoing work will likely explore more innovative solutions to mitigate the effects of poor dietary habits on brain health. Dr. Xu’s legacy will be one of pioneering research that bridges the gap between molecular biology and practical health outcomes, ensuring his work leaves a lasting mark on the fields of neurology and dietary science.

 

Publications


📝 A High-Carbohydrate Diet Induces Cognitive Impairment and Promotes Amyloid Burden and Tau Phosphorylation via PI3K/Akt/GSK-3β Pathway in db/db Mice
Author: Jialu Xu; Lei Xie; Jiaxin Yin; Xiaoli Shi; Kun Dong; Jing Tao; Weijie Xu; Delin Ma; Shujun Zhang; Juan Chen et al.
Journal: Biomedicines
Year: 2024